Challenges and opportunities in international molecular cancer prevention research: An ASPO molecular epidemiology and the environment and international cancer prevention interest groups report

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 11, 2014, Pages 2613-2617

  Epplein, Meira ^a   Bostick, Roberd M ^b,c   Mu, Lina ^d   Ogino, Shuji ^e,f,g   Braithwaite, Dejana ^h   Kanetsky, Peter A ⁱ  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RESEARCH; ENVIRONMENTAL EXPOSURE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RESEARCH; MOLECULAR EPIDEMIOLOGY; MOLECULAR PATHOLOGY; ENVIRONMENT; NEOPLASMS;

BIOMEDICAL RESEARCH; ENVIRONMENT; HUMANS; NEOPLASMS;

EID: 84920171764     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0848     Document Type: Article

References (30)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al., GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] Lyon, France: International Agency for Research on Cancer; 2013.
2. Varmus H, Kumar HS. Addressing the growing international challenge of cancer: a multinational perspective. Sci Transl Med 2013;5:175cm2.
3. Epplein M, Zheng W, Xiang YB, Peek RM, Li H, Correa P, et al. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epi Biomarkers Prev 2012;21:2185-92.
4. MooreHM, Compton CC, Alper J, Vaught JB. International approaches to advancing biospecimen science. Cancer Epidemiol Biomarkers Prev 2011;20:729-32.
5. Vaught J, Rogers J, Myers K, Lim MD, Lockhart N, Moore H, et al. An NCI perspective on creating sustainable biospecimen resources. J Natl Cancer Inst Monogr 2011;2011:1-7.
6. Yassin R, Lockhart N, Gonzalez del Riego M, Pitt K, Thomas JW, Weiss L, et al. Custodianship as an ethical framework for biospecimen-based research. Cancer Epidemiol Biomarkers Prev 2010;19:1012-5.
7. Application of biomarkers in cancer epidemiology. In:Tonolia P, Boffetta P, Shuker DEG, Rothman N, Hulka B, Pearce N, editors. IARC Scientifica Publications, No, 142. Lyon: International Agency for Research on Cancer; 1997.
8. Holland NT, Smith MT, Eskenazi B, Bastaki M. Biological sample collection and processing for molecular epidemiological studies. Mutat Res 2003;543:217-34.
9. Vaught JB, Henderson MK. Biological sample collection, processing, storage and information management. IARC Sci Publ 2011;163:23-42.
10. Harris R, Browning R. Evidence of data access challenges. In:Harris R, Browning R, editors. Global monitoring - The challenges of access to data. Oregon: Cavendish Publishing; 2005. p. 43-52.
11. Yeatts KB, El-Sadig M, Ali HI, Al-Maskari F, Campbell A, Ng SW, et al. Conducting environmental health research in the Arabian Middle East: lessons learned and opportunities. Environ Health Perspect 2012;120:632-6.
12. Fitzgibbon JE, Wallis CL. Laboratory challenges conducting international clinical research in resource-limited settings. J Acquir Immune De fic Syndr 2014;65:S36-9.
13. Elliott KC, Resnik DB. Science, policy, and the transparency of values. Environ Health Perspect 2014;122:647-650.
14. Reid BC, Ghazarian AA, DeMarini DM, Sapkota A, Jack D, Lan Q, et al. Research opportunities for cancer associated with indoor air pollution from solid-fuel combustion. Environ Health Perspect 2012;120:1495-8.
15. Qiu J. China goes back to basics on research funding. Nature 2014;507:148-9.
16. Ogino S, Fuchs CS, Giovannucci E. How many molecular subtypes? Implications of the unique tumor principle in personalized medicine. Expert Rev Mol Diagn 2012;12:621-8.
17. Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, et al. Molecular pathological epidemiology of epigenetics: Emerging integrative science to analyze environment, host, and disease. Mod Pathol 2013;26:465-84.
18. Ogino S, Stampfer M. Lifestyle factors and microsatellite instability in colorectal cancer: The evolving fi eld of molecular pathological epidemiology. J Natl Cancer Inst 2010;102:365-7.
19. Ogino S, Chan AT, Fuchs CS, Giovanni E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011;60:397-411.
20. Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-term colorectal cancer incidence and mortality after lower endoscopy. N Engl J Med 2013;369:1095-105.
21. Nishihara R,Morikawa T, Kuchiba A, Lochhead P, Yamauchi M, Liao X, et al. A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification. Am J Epidemiol 2013;178:84-100.
22. Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, et al. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 2012;367:1596-606.
23. Domingo E, Church DN, Sieber O, Ramamoorthy R, Yanagisawa Y, Johnstone E, et al. Evaluation of PIK3CA mutation as a predictor of benefi t from NSAID therapy in colorectal cancer. J Clin Oncol 2013; 31:4297-305.
24. Abbenhardt C, Poole EM, Kulmacz RJ, Xiao L, Curtin K, Galbraith RL, et al. Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. Int J Mol Epidemiol Genet 2013;4:140-9.
25. Buchanan DD, Win AK, Walsh MD, Walters RJ, Clendenning M, Nagler B, et al. Family history of colorectal cancer in BRAF p.V600Emutated colorectal cancer cases. Cancer Epidemiol Biomarkers Prev 2013;22:917-26.
26. Burnett-Hartman AN, Newcomb PA, Potter JD, Passarelli MN, Phipps AI, Wurscher MA, et al. Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res 2013;73:2863-72.
27. Hoffmeister M, Blaker H, Kloor M, Roth W, Toth C, Herpel E, et al. Body mass index and microsatellite instability in colorectal cancer: a population-based study. Cancer Epidemiol Biomarkers Prev 2013;22:2303-11.
28. Zhu Y, Yang SR, Wang PP, Savas S, Wish T, Zhao J, et al. Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype. Br J Cancer 2014; 110:1359-66.
29. Ogino S, King EE, Beck AH, Sherman ME, Milner DA, Giovannucci E. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am J Epidemiol 2012;176:659-67.
30. Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene 2014;33:2949-55.